Search Results
May 26, 2026, 03:00 ET MatOrtho annonce le classement ReCerf® 5A* ODEP
spécialisée dans les technologies de resurfaçage de la hanche et de remplacement du genou.Relations avec les médias :Michael Watson PhD MCIMChef du marketing et de la gestion des produitsMatOrthoTél : 01372 224200Email :
More news about: MatOrtho
May 26, 2026, 00:35 ET Over 40 Studies Featuring Akeso's Innovative Oncology Agents to Be Presented at ASCO 2026: Ivonescimab's HARMONi-6 Overall Survival Data Selected for Plenary Session
colorectal cancer (mCRC): A phase II studyAbstract: 3576Date: May 30, 2026First Author: David Berz, MD, PhD, Department of Oncology, Valkyrie Clinical Trials, IncAbout AkesoAkeso (HKEX: 9926.HK) is a leading biopharmaceutical company
More news about: Akeso, Inc.
May 25, 2026, 22:53 ET Hansa Biopharma Announces Late-Breaking Abstract from ConfIdeS Phase 3 Trial Selected for Oral Presentation at ATC 2026
including the primary endpoint eGFR, key secondary endpoints as well as safety results. The presentation will be delivered by Dr Robert Montgomery, MD PhD, New York University Langone Transplant Institute and investigator in the ConfIdeS trial.Title: Superior 1-year eGFR Among Highly Sensitized
More news about: Hansa Biopharma AB
May 25, 2026, 22:52 ET Hansa Biopharma Announces Late-Breaking Abstract from ConfIdeS Phase 3 Trial Selected for Oral Presentation at ATC 2026
including the primary endpoint eGFR, key secondary endpoints as well as safety results. The presentation will be delivered by Dr Robert Montgomery, MD PhD, New York University Langone Transplant Institute and investigator in the ConfIdeS trial.Title: Superior 1-year eGFR Among Highly Sensitized
More news about: Hansa Biopharma AB
May 22, 2026, 18:13 ET Coppin State University Celebrates the Class of 2026 During 126th Commencement Ceremony
careers. "Go out into this world, and take up some space. We need you in every room where power is assembled," said Alsobrooks. Anthony L. Jenkins, PhD, President of Coppin State University, congratulated graduates and reflected on the university's continued momentum in student success, enrollment growth,
More news about: Coppin State University
May 22, 2026, 13:24 ET AAPACN Applauds the Appointment of Dr. Danielle Pierotti to the Medicare Payment Advisory Commission (MedPAC)
2026 /PRNewswire/ -- The American Association of Post-Acute Care Nursing (AAPACN®) proudly announces that Board member Danielle Pierotti, PhD, RN, has been appointed to the Medicare Payment Advisory Commission (MedPAC) for a three-year term. Dr. Pierotti was nominated for this prestigious position
More news about: American Association of Post-Acute Care Nursing
May 22, 2026, 09:09 ET Obesity Action Coalition Extends Early Bird Pricing for the Your Weight Matters National Convention Through June 22
respected voices in obesity care. This year's speaker lineup includes nationally recognized experts such as Ania Jastreboff, PhD, MD, Robyn Pashby, PhD, Michael Albert, MD and Renee Rogers, PhD along with many other leaders in obesity medicine, research and patient-centered care.Attendees will have access
More news about: Obesity Action Coalition
May 22, 2026, 08:15 ET Psilera, Inc. to Present at Upcoming Industry and Investor Conferences
Date: June 22 – June 25, 2026Location: San Diego, CAPsilera Representatives: Chris Witowski, PhD (Co-Founder & CEO) and Magali Haas, MD-PhD (Chief Medical Officer)Details: Members of the executive team will be on-site to share the company's latest preclinical
More news about: Psilera, Inc.
May 22, 2026, 08:00 ET Parker Institute for Cancer Immunotherapy Brings the Power of Its Integrated Network to ASCO 2026
(Allison Betof, MD, PhD — Stanford): A multicenter Phase 2 trial of relatlimab, nivolumab, and ipilimumab in patients with asymptomatic and symptomatic melanoma brain metastases (Abstract TPS9604, lead author).OBX-115 TIL Therapy (Allison Betof, MD, PhD — Stanford): Phase 2
More news about: Parker Institute for Cancer Immunotherapy
May 22, 2026, 07:30 ET The Farmer's Dog Announces Partnership with 'The Oprah Podcast' Featuring Custom Mini-series Dedicated to the Bond Between Dogs and Their Owners
processed meal plans designed to help dogs live longer, healthier lives. Our on-staff team of Board-Certified Veterinary Nutritionists®, PhD nutritionists, and veterinarians work to develop recipes packed with the nutrients dogs need, while avoiding the downsides of excess processing. Every
More news about: The Farmer's Dog
May 22, 2026, 05:00 ET Scientists Unlock Scalable Production of Human Gut Organoids with Functional Nerves
functional small-intestine tissue compared with about 1 centimeter using earlier protocols.The study, led by Holly Poling, PhD, with senior author Maxime Mahe, PhD, and 17 colleagues at Cincinnati Children's and Nantes Université, addresses a central bottleneck in organoid science: how to move
More news about: Cincinnati Children's Hospital Medical Center
May 21, 2026, 18:39 ET AANP TAKES LEGAL ACTION TO PROTECT FUTURE NURSE PRACTITIONERS AND PATIENT ACCESS TO CARE
profession."America's health care system needs more providers, not more barriers for students pursuing careers in health care," said AANP President Valerie J. Fuller, PhD, DNP. "This rule threatens the ability of future nurse practitioners to complete their education at a time when patients are already struggling to access
More news about: American Association of Nurse Practitioners (AANP)
May 21, 2026, 17:17 ET Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress
AcceleRET-Lung studySanjay Popat, MBBS, FRCP, PhDOral presentation #8504
More news about: Rigel Pharmaceuticals, Inc.
May 21, 2026, 17:05 ET Whitehawk Therapeutics Expands ADC Pipeline with New Option Agreement for Use of CPT113 Linker-Payload
our proprietary CBCR bioconjugation process, we believe we further enhance ADC stability to deliver potential best-in-class ADCs," said Dave Lennon, PhD, President and Chief Executive Officer of Whitehawk Therapeutics. "With HWK-007 and HWK-016 enrolling, and an IND for HWK-206 anticipated mid-year, we
More news about: Whitehawk Therapeutics, Inc.
May 21, 2026, 17:00 ET Servier Presentations at ASCO 2026 Spotlight Expanding Rare Oncology Portfolio
our newer oncology programs—underscore our dedication to delivering transformative medicines to patients with high unmet needs," said Becky Martin, PhD, Chief of Medical, Servier Pharmaceuticals. "Together, these programs demonstrate the continued evolution of Servier's oncology portfolio and our growing
More news about: Servier Pharmaceuticals
May 21, 2026, 16:15 ET David P. King elected to Illumina's Board of Directors
Fortune as one of the World's Most Admired Companies.Mr. King joins the Board following the retirement of Frances Arnold, PhD, Robert S. Epstein, MD, and Gary S. Guthart, PhD, each of whom concluded distinguished tenures on the Board at the company's annual meeting.About David P. KingDavid
More news about: Illumina, Inc.
May 21, 2026, 14:42 ET Marquis Who's Who : Michael E. Kounavis, PhD - Innovation in Data and Artificial Intelligence
SCARSDALE, N.Y., May 21, 2026 /PRNewswire/ -- With three decades of experience, Michael E. Kounavis, PhD, has solidified himself as a senior industry leader whose achievements Marquis Who's Who is proud to recognize. Specializing in computer science, particularly
More news about: Marquis Who's Who
May 21, 2026, 12:00 ET HDT Bio and UTMB Receive MCDC Innovation Prototype Award for Advancing CCHF Vaccine from Lab to Phase 1 Clinical Trial
team and the strength of our partnerships with NIH/NIAID, UTMB, and the Department of War," said Steve Reed, PhD, Chief Executive Officer of HDT Bio, whose sentiment was echoed by Jesse Erasmus, PhD, Director of Virology and Principal Investigator of the program, "Taking HDT-321 from early preclinical work
More news about: HDT Bio Corp.
May 21, 2026, 11:58 ET Long Island University Launches AI² Center to Advance Artificial Intelligence Education, Research, and Innovation
AI-expert postdoctoral fellows, as well as open studio hours in LIU's state-of-the-art 3DS simulation and fabrication labs.Led by Mohammed Cherkaoui, PhD, Senior Vice President for Research and Artificial Intelligence, the AI² Center advances LIU's leadership in artificial intelligence, interdisciplinary
More news about: Long Island University
May 21, 2026, 11:48 ET Outcomes4Me Acquires Geno.Me and Realyze Intelligence, Names UPMC Hillman Cancer Center CIO as Strategic Advisor, to Expedite AI-driven Cancer Care and Clinical Trial Access
embedding it directly into clinical workflows in a way that accelerates research, reduces costs, and improves patient outcomes," said Gilan El Saadawi, MD, PhD, Co-founder of Realyze Intelligence. "The combination of Realyze's AI-powered clinical trial matching capabilities with a trusted, consumer-focused platform
More news about: Outcomes4Me Inc.
May 21, 2026, 10:15 ET LEVEL Sleep Protab Improved Sleep Quality and Next-Morning Outcomes in Independent 29-Day Study
slept longer. They slept better, and they woke up feeling better, without the next-day grogginess most sleep aids are known for," said Chris Emerson, PhD, founder and CEO of LEVEL. "Consistency mattered more than dose. Participants who took the Sleep Protab regularly showed the largest improvements on
More news about: LEVEL
May 21, 2026, 09:11 ET The "Master of Communication" on Why Healthcare Professionals Are America's Most Underserved Learners
medical education to support their pharmaceutical clients with the ultimate goal of improving patient lives.Founded by Stephen M. Stahl, MD, PhD, DSc (Hon), DMedSci (Hon, Cambridge), and Richard Davis, ASG sets themselves apart in the agency landscape by not only executing tactics but also acting
More news about: Arbor Scientia Group
May 21, 2026, 08:47 ET FDA Veteran Paz Vellanki, MD, PhD, Joins Precision for Medicine, Forming a Trio of Former Regulatory Leaders
/PRNewswire/ -- Precision for Medicine, a global leader in biomarker-driven clinical research and development, today announced that Paz Vellanki, MD, PhD, has joined the company as Vice President, Clinical Development, Oncology. She most recently served as Associate Director of the Division of Oncology
More news about: Precision for Medicine
May 21, 2026, 08:30 ET Overcoming Challenges in Viral Vector Manufacturing to Meet Commercial Demand for Gene Therapies, Upcoming Webinar Hosted by Xtalks
learn how viral vector manufacturing strategies can improve scale-up, reduce risk and support commercial gene therapy supply.Join Emigdio Reyes, PhD, Director of Upstream Process Development,
More news about: Xtalks
May 21, 2026, 08:30 ET From Strategy to Approval: Case Studies in Advancing Clinical Programs for Emerging Biotech, Upcoming Webinar Hosted by Xtalks
Fortrea, Mark Lovern (Moderator), PhD, Executive Director of Medical Science Services; Alicia Baker McDowell, DRSc, MS, EMBA, Vice President and Head of Global Regulatory Consulting; Todd
More news about: Xtalks